ID   CBP_RAT                 Reviewed;        2442 AA.
AC   Q6JHU9;
DT   31-MAY-2011, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   02-OCT-2024, entry version 149.
DE   RecName: Full=Histone lysine acetyltransferase CREBBP;
DE            EC=2.3.1.48 {ECO:0000250|UniProtKB:Q92793};
DE   AltName: Full=Protein lactyltransferas CREBBP;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q92793};
DE   AltName: Full=Protein-lysine acetyltransferase CREBBP;
DE            EC=2.3.1.- {ECO:0000250|UniProtKB:Q92793};
GN   Name=Crebbp; Synonyms=Cbp;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND INDUCTION.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=15950780; DOI=10.1016/j.molbrainres.2005.03.009;
RA   Tang C., Sula M.J., Bohnet S., Rehman A., Taishi P., Krueger J.M.;
RT   "Interleukin-1beta induces CREB-binding protein (CBP) mRNA in brain and the
RT   sequencing of rat CBP.";
RL   Brain Res. Mol. Brain Res. 137:213-222(2005).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2064, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Acetylates histones, giving a specific tag for
CC       transcriptional activation (By similarity). Mediates acetylation of
CC       histone H3 at 'Lys-18' and 'Lys-27' (H3K18ac and H3K27ac, respectively)
CC       (By similarity). Also acetylates non-histone proteins, like DDX21, FBL,
CC       IRF2, MAFG, NCOA3, POLR1E/PAF53 and FOXO1 (By similarity). Binds
CC       specifically to phosphorylated CREB and enhances its transcriptional
CC       activity toward cAMP-responsive genes. Acts as a coactivator of ALX1.
CC       Acts as a circadian transcriptional coactivator which enhances the
CC       activity of the circadian transcriptional activators: NPAS2-BMAL1 and
CC       CLOCK-BMAL1 heterodimers (By similarity). Acetylates PCNA; acetylation
CC       promotes removal of chromatin-bound PCNA and its degradation during
CC       nucleotide excision repair (NER) (By similarity). Acetylates
CC       POLR1E/PAF53, leading to decreased association of RNA polymerase I with
CC       the rDNA promoter region and coding region (By similarity). Acetylates
CC       DDX21, thereby inhibiting DDX21 helicase activity (By similarity).
CC       Acetylates FBL, preventing methylation of 'Gln-105' of histone H2A
CC       (H2AQ104me) (By similarity). In addition to protein acetyltransferase,
CC       can use different acyl-CoA substrates, such as lactoyl-CoA, and is able
CC       to mediate protein lactylation (By similarity). Catalyzes lactylation
CC       of MRE11 in response to DNA damage, thereby promoting DNA double-strand
CC       breaks (DSBs) via homologous recombination (HR) (By similarity).
CC       Functions as a transcriptional coactivator for SMAD4 in the TGF-beta
CC       signaling pathway (By similarity). {ECO:0000250|UniProtKB:P45481,
CC       ECO:0000250|UniProtKB:Q92793}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[histone] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[histone]; Xref=Rhea:RHEA:21992, Rhea:RHEA-COMP:9845,
CC         Rhea:RHEA-COMP:11338, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000250|UniProtKB:Q92793};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930;
CC         Evidence={ECO:0000250|UniProtKB:Q92793};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(S)-lactoyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-[(S)-
CC         lactoyl]-L-lysyl-[protein]; Xref=Rhea:RHEA:61996, Rhea:RHEA-
CC         COMP:9752, Rhea:RHEA-COMP:19466, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:231527,
CC         ChEBI:CHEBI:231528; Evidence={ECO:0000250|UniProtKB:Q92793};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:61997;
CC         Evidence={ECO:0000250|UniProtKB:Q92793};
CC   -!- SUBUNIT: Part of a complex composed of MSX3, CREBBP/CBP AND EP300/p300;
CC       the interaction with MSX3 decreases histone acetylation activity (By
CC       similarity). Found in a complex containing NCOA2; NCOA3; IKKA; IKKB and
CC       IKBKG. Probably part of a complex with HIF1A and EP300. Interacts with
CC       phosphorylated CREB1. Interacts with the C-terminal region of CITED4.
CC       The TAZ-type 1 domain interacts with HIF1A. Interacts with SRCAP,
CC       CARM1, ELF3, MLLT7/FOXO4, N4BP2, NCOA1, NCOA3, NCOA6, PCAF, DDX5,
CC       DDX17, PELP1, PML, SMAD1, SMAD2, SMAD3, SPIB, TRERF1 and ZCCHC12.
CC       Interacts with KLF1; the interaction results in acetylation and
CC       enhancement of transcriptional activity of KLF1. Interacts with DAXX;
CC       the interaction is dependent on CBP sumoylation and results in
CC       suppression of the transcriptional activity via recruitment of HDAC2 to
CC       DAXX. Interacts with MAF. Interacts with MTDH. Interacts with MAFG; the
CC       interaction acetylates MAFG in the basic region and stimulates NFE2
CC       transcriptional activity through increasing its DNA-binding activity.
CC       Interacts with IRF2; the interaction acetylates IRF2 and regulates its
CC       activity on the H4 promoter. Interacts (via N-terminus) with
CC       SS18L1/CREST (via C-terminus) (By similarity). Interacts with IRF3
CC       (when phosphorylated); forming the dsRNA-activated factor 1 (DRAF1), a
CC       complex which activates the transcription of the type I interferon
CC       genes (By similarity). Interacts with MECOM. Interacts with CITED1 (via
CC       C-terminus) Interacts with GATA1; the interaction results in
CC       acetylation and enhancement of transcriptional activity of GATA1.
CC       Interacts with FOXO1; the interaction acetylates FOXO1 and inhibits its
CC       transcriptional activity. Interacts with NPAS2, CLOCK and BMAL1.
CC       Interacts with ASF1A and ASF1B; this promotes histone acetylation.
CC       Interacts with acetylated TP53/p53 and with the acetylated histones H3
CC       and H4. Interacts (via transactivation domain and C-terminus) with
CC       PCNA; the interaction occurs on chromatin in UV-irradiated damaged
CC       cells. Interacts with DHX9 (via N-terminus); this interaction mediates
CC       association with RNA polymerase II holoenzyme and stimulates CREB-
CC       dependent transcriptional activation (By similarity). Interacts with
CC       SMAD4; negatively regulated by ZBTB7A (By similarity). Forms a complex
CC       with KMT2A and CREB1 (By similarity). Interacts with DDX3X; this
CC       interaction may facilitate HNF4A acetylation (By similarity). Interacts
CC       with MSX1; the interaction may inhibit MSX1 autoinactivation (By
CC       similarity). Interacts with MSX3 (By similarity). Interacts with ACSS2
CC       (By similarity). {ECO:0000250|UniProtKB:P45481,
CC       ECO:0000250|UniProtKB:Q92793}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q92793}. Nucleus
CC       {ECO:0000255|PROSITE-ProRule:PRU00311}. Note=Recruited to nuclear
CC       bodies by SS18L1/CREST. In the presence of ALX1 relocalizes from the
CC       cytoplasm to the nucleus. {ECO:0000250|UniProtKB:Q92793}.
CC   -!- TISSUE SPECIFICITY: Expressed in hypothalamus and cortex.
CC       {ECO:0000269|PubMed:15950780}.
CC   -!- INDUCTION: Up-regulated by IL-1 treatment.
CC       {ECO:0000269|PubMed:15950780}.
CC   -!- PTM: Methylation of the KIX domain by CARM1 blocks association with
CC       CREB. This results in the blockade of CREB signaling, and in activation
CC       of apoptotic response (By similarity). {ECO:0000250|UniProtKB:P45481}.
CC   -!- PTM: Phosphorylated by CHUK/IKKA at Ser-1383 and Ser-1387; these
CC       phosphorylations promote cell growth by switching the binding
CC       preference of CREBBP from TP53 to NF-kappa-B.
CC       {ECO:0000250|UniProtKB:Q92793}.
CC   -!- PTM: Sumoylation negatively regulates transcriptional activity via the
CC       recruitment of DAAX. {ECO:0000250|UniProtKB:P45481}.
CC   -!- PTM: Autoacetylation is required for binding to protein substrates,
CC       such as acetylated histones and acetylated TP53/p53. Autoacetylation is
CC       induced by glucose and fatty acids. {ECO:0000250|UniProtKB:Q92793}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY462245; AAR23149.1; -; mRNA.
DR   AlphaFoldDB; Q6JHU9; -.
DR   BMRB; Q6JHU9; -.
DR   SMR; Q6JHU9; -.
DR   IntAct; Q6JHU9; 1.
DR   MINT; Q6JHU9; -.
DR   STRING; 10116.ENSRNOP00000007079; -.
DR   iPTMnet; Q6JHU9; -.
DR   PhosphoSitePlus; Q6JHU9; -.
DR   PaxDb; 10116-ENSRNOP00000007079; -.
DR   UCSC; RGD:2401; rat.
DR   AGR; RGD:2401; -.
DR   RGD; 2401; Crebbp.
DR   eggNOG; KOG1778; Eukaryota.
DR   InParanoid; Q6JHU9; -.
DR   Reactome; R-RNO-1234158; Regulation of gene expression by Hypoxia-inducible Factor.
DR   Reactome; R-RNO-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-RNO-3134973; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production.
DR   Reactome; R-RNO-3371568; Attenuation phase.
DR   Reactome; R-RNO-350054; Notch-HLH transcription pathway.
DR   Reactome; R-RNO-400206; Regulation of lipid metabolism by PPARalpha.
DR   Reactome; R-RNO-8866907; Activation of the TFAP2 (AP-2) family of transcription factors.
DR   Reactome; R-RNO-8939246; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells.
DR   Reactome; R-RNO-8941856; RUNX3 regulates NOTCH signaling.
DR   Reactome; R-RNO-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-RNO-933541; TRAF6 mediated IRF7 activation.
DR   Reactome; R-RNO-9617629; Regulation of FOXO transcriptional activity by acetylation.
DR   Reactome; R-RNO-9707564; Cytoprotection by HMOX1.
DR   Reactome; R-RNO-9759194; Nuclear events mediated by NFE2L2.
DR   Reactome; R-RNO-9856649; Transcriptional and post-translational regulation of MITF-M expression and activity.
DR   PRO; PR:Q6JHU9; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0000785; C:chromatin; ISO:RGD.
DR   GO; GO:0005737; C:cytoplasm; ISO:RGD.
DR   GO; GO:0000123; C:histone acetyltransferase complex; ISO:RGD.
DR   GO; GO:0016604; C:nuclear body; IDA:RGD.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0000940; C:outer kinetochore; ISO:RGD.
DR   GO; GO:0032991; C:protein-containing complex; ISO:RGD.
DR   GO; GO:0090575; C:RNA polymerase II transcription regulator complex; ISO:RGD.
DR   GO; GO:0005667; C:transcription regulator complex; IDA:RGD.
DR   GO; GO:0016407; F:acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0008140; F:cAMP response element binding protein binding; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IBA:GO_Central.
DR   GO; GO:0003684; F:damaged DNA binding; ISS:UniProtKB.
DR   GO; GO:0097718; F:disordered domain specific binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0140297; F:DNA-binding transcription factor binding; IPI:RGD.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:RGD.
DR   GO; GO:0043993; F:histone H3K18 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0044017; F:histone H3K27 acetyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0060090; F:molecular adaptor activity; ISO:RGD.
DR   GO; GO:0043426; F:MRF binding; ISS:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; ISO:RGD.
DR   GO; GO:0120300; F:peptide lactyltransferase (CoA-dependent) activity; ISS:UniProtKB.
DR   GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; ISO:RGD.
DR   GO; GO:0042975; F:peroxisome proliferator activated receptor binding; IDA:RGD.
DR   GO; GO:0019904; F:protein domain specific binding; ISO:RGD.
DR   GO; GO:0044877; F:protein-containing complex binding; IPI:RGD.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0061629; F:RNA polymerase II-specific DNA-binding transcription factor binding; ISO:RGD.
DR   GO; GO:0046332; F:SMAD binding; IPI:RGD.
DR   GO; GO:0001093; F:TFIIB-class transcription factor binding; ISO:RGD.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0001223; F:transcription coactivator binding; IPI:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0008270; F:zinc ion binding; ISO:RGD.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
DR   GO; GO:0007249; P:canonical NF-kappaB signal transduction; ISO:RGD.
DR   GO; GO:0035729; P:cellular response to hepatocyte growth factor stimulus; ISO:RGD.
DR   GO; GO:0031669; P:cellular response to nutrient levels; ISO:RGD.
DR   GO; GO:0034644; P:cellular response to UV; ISS:UniProtKB.
DR   GO; GO:0098586; P:cellular response to virus; ISO:RGD.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; ISO:RGD.
DR   GO; GO:0007616; P:long-term memory; IMP:RGD.
DR   GO; GO:0032688; P:negative regulation of interferon-beta production; ISO:RGD.
DR   GO; GO:0016479; P:negative regulation of transcription by RNA polymerase I; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0048525; P:negative regulation of viral process; ISO:RGD.
DR   GO; GO:0060355; P:positive regulation of cell adhesion molecule production; IMP:RGD.
DR   GO; GO:0060999; P:positive regulation of dendritic spine development; IMP:RGD.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; ISS:UniProtKB.
DR   GO; GO:1900087; P:positive regulation of G1/S transition of mitotic cell cycle; IMP:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:1901224; P:positive regulation of non-canonical NF-kappaB signal transduction; IMP:RGD.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISO:RGD.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; ISO:RGD.
DR   GO; GO:0031648; P:protein destabilization; ISS:UniProtKB.
DR   GO; GO:0036211; P:protein modification process; IDA:RGD.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; IDA:RGD.
DR   GO; GO:0070555; P:response to interleukin-1; IEP:RGD.
DR   GO; GO:0002931; P:response to ischemia; IEP:RGD.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   CDD; cd05495; Bromo_cbp_like; 1.
DR   CDD; cd20910; NCBD_CREBBP-p300_like; 1.
DR   CDD; cd15557; PHD_CBP_p300; 1.
DR   CDD; cd15802; RING_CBP-p300; 1.
DR   CDD; cd02337; ZZ_CBP; 1.
DR   Gene3D; 2.10.110.40; -; 1.
DR   Gene3D; 3.30.60.90; -; 1.
DR   Gene3D; 1.20.920.10; Bromodomain-like; 1.
DR   Gene3D; 1.10.246.20; Coactivator CBP, KIX domain; 1.
DR   Gene3D; 1.10.1630.10; Nuclear receptor coactivator, CREB-bp-like, interlocking domain; 1.
DR   Gene3D; 1.20.1020.10; TAZ domain; 2.
DR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR031162; CBP_P300_HAT.
DR   InterPro; IPR013178; Histone_AcTrfase_Rtt109/CBP.
DR   InterPro; IPR003101; KIX_dom.
DR   InterPro; IPR036529; KIX_dom_sf.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014744; Nuc_rcpt_coact_CREBbp.
DR   InterPro; IPR037073; Nuc_rcpt_coact_CREBbp_sf.
DR   InterPro; IPR010303; RING_CBP-p300.
DR   InterPro; IPR038547; RING_CBP-p300_sf.
DR   InterPro; IPR035898; TAZ_dom_sf.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000197; Znf_TAZ.
DR   InterPro; IPR000433; Znf_ZZ.
DR   InterPro; IPR043145; Znf_ZZ_sf.
DR   PANTHER; PTHR13808; CBP/P300-RELATED; 1.
DR   PANTHER; PTHR13808:SF34; CREB-BINDING PROTEIN; 1.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF09030; Creb_binding; 1.
DR   Pfam; PF08214; HAT_KAT11; 1.
DR   Pfam; PF02172; KIX; 1.
DR   Pfam; PF06001; RING_CBP-p300; 1.
DR   Pfam; PF02135; zf-TAZ; 2.
DR   Pfam; PF00569; ZZ; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM01250; KAT11; 1.
DR   SMART; SM00551; ZnF_TAZ; 2.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF47370; Bromodomain; 1.
DR   SUPFAM; SSF47040; Kix domain of CBP (creb binding protein); 1.
DR   SUPFAM; SSF69125; Nuclear receptor coactivator interlocking domain; 1.
DR   SUPFAM; SSF57850; RING/U-box; 1.
DR   SUPFAM; SSF57933; TAZ domain; 2.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51727; CBP_P300_HAT; 1.
DR   PROSITE; PS50952; KIX; 1.
DR   PROSITE; PS50134; ZF_TAZ; 2.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Activator; Acyltransferase; Biological rhythms; Bromodomain;
KW   Coiled coil; Cytoplasm; Isopeptide bond; Metal-binding; Methylation;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   CHAIN           2..2442
FT                   /note="Histone lysine acetyltransferase CREBBP"
FT                   /id="PRO_0000409385"
FT   DOMAIN          586..665
FT                   /note="KIX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00311"
FT   DOMAIN          1104..1176
FT                   /note="Bromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          1324..1701
FT                   /note="CBP/p300-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01065"
FT   ZN_FING         346..432
FT                   /note="TAZ-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00203"
FT   ZN_FING         1703..1751
FT                   /note="ZZ-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   ZN_FING         1766..1847
FT                   /note="TAZ-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00203"
FT   REGION          1..40
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          74..168
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          226..409
FT                   /note="Interaction with SRCAP"
FT                   /evidence="ECO:0000250"
FT   REGION          261..290
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          792..1084
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1125..1171
FT                   /note="Interaction with histone"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   REGION          1163..1181
FT                   /note="Interaction with ASF1A"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   REGION          1434..1436
FT                   /note="Interaction with histone"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   REGION          1557..1616
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1875..1960
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          2112..2421
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          1548..1575
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        18..32
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        262..290
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        792..849
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        850..864
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        874..889
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        890..930
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        939..991
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        999..1066
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1067..1082
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1557..1572
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1589..1603
FT                   /note="Basic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1884..1917
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1922..1939
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1941..1955
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2112..2146
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2163..2187
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2196..2266
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2277..2350
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2351..2378
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        2395..2421
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         362
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         366
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         379
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         384
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         393
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         397
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         403
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         408
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         417
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         421
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         426
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         429
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="3"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   BINDING         1435..1437
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   BINDING         1447..1448
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   BINDING         1494
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   BINDING         1499
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   BINDING         1503
FT                   /ligand="acetyl-CoA"
FT                   /ligand_id="ChEBI:CHEBI:57288"
FT                   /evidence="ECO:0000250|UniProtKB:Q09472"
FT   BINDING         1708
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1711
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1721
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1724
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1730
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1733
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1739
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   BINDING         1741
FT                   /ligand="Zn(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29105"
FT                   /ligand_label="5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         120
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         219
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         600
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   MOD_RES         624
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   MOD_RES         656
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   MOD_RES         1015
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1031
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1077
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1217
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1383
FT                   /note="Phosphoserine; by IKKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1387
FT                   /note="Phosphoserine; by IKKA"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1584
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1592
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1593
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1596
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1598
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1742
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1745
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         1764
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         2064
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         2077
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         2080
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q92793"
FT   MOD_RES         2351
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   CROSSLNK        999
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   CROSSLNK        1034
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
FT   CROSSLNK        1057
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000250|UniProtKB:P45481"
SQ   SEQUENCE   2442 AA;  265424 MW;  2E77EF213C72C024 CRC64;
     MAENLLDGPP NPKRAKLSSP GFSANDSTDF GSLFDLENDL PDELIPNGEL SLLNSGNLVP
     DAASKHKQLS ELLRGGSGSS ITPGIGNVSA SSPVQQGLGG QAQGQPNSTS MASLGAMGKS
     PLNPGDSSTP SLPKQAASTS GPTPPASQAL NPQAQKQVGL VTSSPATSQT GPGICMNANF
     NQTHPGLLNS NSGHSLMNQA QQGQAQVMNG SLGAAGRGRG AGMPYPAPAM QGATSSVLAE
     TLTQVSPQMA GHAGLNTAQA GGMTKMGMTG NTSPFGQPFS QTGGQPMGAT GVNPQLASKQ
     SMVNSLPAFP TDIKNTSVTT VPNMSQLQTS VGIVPAQGIA TGPTADPEKR KLIQQQLVLL
     LHAHKCQRRE QANGEVRACS LPHCRTMKNV LNHMTHCQAG KACQVAHCAS SRQIISHWKN
     CTRHDCPVCL PLKNASDKRN QQTILGSPAS GIQNTIGSVG AGQQNATSLS NPNPIDPSSM
     QRAYAALGLP YMNQPQTQLQ PQVPGQQPAQ PPAHQQMRTL NALGNNPMSI PAGGITTDQQ
     PPNLISESAL PTSLGATNPL MNDGSNSDSI GSLSTIPTAA PPSSTGVRKG WHEHVTQDLR
     SHLVHKLVQA IFPTPDPAAL KDRRMENLVA YAKKVEGDMY ESANSRDEYY HLLAEKIYKI
     QKELEEKRRS RLHKQGILGN QPALPAPGAQ PPVIPPTQSV RPPNGPLSLP VNRVQVSQGM
     NSFNPMSLGN VQLPQAPMGP RAASPMNHSV QMNSMASVPG MAISPSRMPQ PPNMMGTHAN
     NIMAQAPTQN QFLPQNQFPS SSGAMSVNSV GMGQPATQAG VSQGQVPGGT LPNPLNMLAP
     QTSQLPCPPV TQSPLHPTPP PASTAAGMPS LQHPTPPGMT PPQPAAPTQP STPVSSGQTP
     TPTPGSVPSA AQTQSTPTVQ AAAQAQVTPQ PQTPVQPPSV ATPQSSQQQP TPVHTQPPGT
     PLSQAAASID NRVPTPSSVT SAETSSQQPG PDVPMLEMKT EVQTDDAEPD PAESKGEPRS
     EMMEEDLQGS SQVKEETDTT EQKSEPMEVE EKKPEVKVEA KEEEENSANG TASQSTSPSQ
     PRKKIFKPEE LRQALMPTLE ALYRQDPESL PFRQPVDPQL LGIPDYFDIV KNPMDLSTIK
     RKLDTGQYQE PWQYVDDVWL MFNNAWLYNR KTSRVYKFCS KLAEVFEQEI DPVMQSLGYC
     CGRKYEFSPQ TLCCYGKQLC TIPRDAAYYS YQNRYHFCEK CFTEIQGENV TLGDDPSQPQ
     TTISKDQFEK KKNDTLDPEP FVDCKECGRK MHQICVLHYD IIWPSGFVCD NCLKKTGRPR
     KENKFSAKRL QTTRLGNHLE DRVNKFLRRQ NHPEAGEVFV RVVASSDKTV EVKPGMKSRF
     VDSGEMSESF PYRTKALFAF EEIDGVDVCF FGMHVQEYGS DCPPPNTRRV YISYLDSIHF
     FRPRCLRTAV YHEILIGYLE YVKKLGYVTG HIWACPPSEG DDYIFHCHPP DQKIPKPKRL
     QEWYKKMLDK AFAERIINDY KDIFKQANED RLTSAKELPY FEGDFWPNVL EESIKELEQE
     EEERKKEEST AASETPEGSQ GDSKNAKKKN NKKTNKNKSS ISRANKKKPS MPNVSNDLSQ
     KLYATMEKHK EVFFVIHLHA GPVISTQPPI VDPDPLLSCD LMDGRDAFLT LARDKHWEFS
     SLRRSKWSTL CMLVELHTQG QDRFVYTCNE CKHHVETRWH CTVCEDYDLC INCYNTKSHT
     HKMVKWGLGL DDEGSSQGEP QSKSPQESRR LSIQRCIQSL VHACQCRNAN CSLPSCQKMK
     RVVQHTKGCK RKTNGGCPVC KQLIALCCYH AKHCQENKCP VPFCLNIKHK LRQQQIQHRL
     QQAQLMRRRM ATMNTRNVPQ QSLPSPTSAP PGTPTQQPST PQTPQPPAQP QPSPVNMSPA
     GFPSVARTQP PTIVSAGKPT NQVPAPPPPA QPPPAAVEAA RQIEREGQQQ QHLYRANINN
     GMPPGRAGMG TPGSQMAPVG LNVPRPNQVS GPVMSSMPPG QWQQAPIPQQ QPMPGMPRPV
     MSMQAQAAVA GPRMPNVQPP RSISPSALQD LLRTLKSPSS PQQQQQVLNI LKSNPQLMAA
     FIKQRTAKYV ANQPGMQPQP GLQSQPGMQP QPGMHQQPSL QNLNAMQAGV PRPGVPPPQQ
     AMGGLNPQGQ ALNIMNPGHN PNMANMNPQY REMVRRQLLQ HQQQQQQQQQ QQQQQQQSSA
     SLAGGMAGHS QFQQPQGPGG YAPAMQQQRM QQHLPIQGSS MGQMAAPMGQ LGQMGQPGLG
     ADSTPNIQQA LQQRILQQQQ MKQQIGSPGQ PNPMSPQQHM LSGQPQASHL PGQQIATSLS
     NQVRSPAPVQ SPRPQSQPPH SSPSPRIQPQ PSPHHVSPQT GSPHPGLAVT MASSMDQGHL
     GNPEQSAMLP QLNTPNRSAL SSELSLVGDT TGDTLEKFVE GL
//
